Product Portfolio

PharmaciaPolonica has developed a generic product, containing cytisine as active substance, intended to be used in the treatment of nicotine dependence. Product developed with co-financing from Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects".

Cytisine, 1.5 mg, tablets obtained marketing authorization in the following countries: Austria, Belgium, Czech Republic, Germany, Denmark, Spain, Ireland, Netherlands, Poland, Romania, Sweden.

Currently PharmaciaPolonica offers marketing authorization rights for sale or attractive licensing-out opportunities for this product.


Please contact us for further information at